The makers of EpiPen are now facing lower priced competition from a generic version that sells for just $109.99 for a two-pack as opposed to $600 or more.
CVS is marketing the cheaper allergy drug in over 9,500 stores Across the US.
Just a few months ago Mylan NV was verbally beaten for dramatically raising prices of their EpiPen.
It takes a while sometimes, but it’s beautiful watching the competitive free market at work like this.
Hat Tip to Dr. Sanford Ikeda for sharing this story on his Facebook feed.
